535 related articles for article (PubMed ID: 19418101)
1. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
2. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
3. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.
Huebner M; Kendrick M; Reid-Lombardo KM; Que F; Therneau T; Qin R; Donohue J; Nagorney D; Farnell M; Sarr M
J Gastrointest Surg; 2012 May; 16(5):920-6. PubMed ID: 22421988
[TBL] [Abstract][Full Text] [Related]
4. Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma.
Ashfaq A; Pockaj BA; Gray RJ; Halfdanarson TR; Wasif N
J Gastrointest Surg; 2014 Nov; 18(11):1929-35. PubMed ID: 24916590
[TBL] [Abstract][Full Text] [Related]
5. Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East.
Shamseddine AI; Mukherji D; Melki C; Elias E; Eloubeidi M; Dimassi H; Khalife M; Abou-Alfa G; O'Reilly E; Faraj W
Am J Clin Oncol; 2014 Feb; 37(1):13-8. PubMed ID: 23111358
[TBL] [Abstract][Full Text] [Related]
6. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
Berger AC; Watson JC; Ross EA; Hoffman JP
Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
Morales-Oyarvide V; Rubinson DA; Dunne RF; Kozak MM; Bui JL; Yuan C; Qian ZR; Babic A; Da Silva A; Nowak JA; Khalaf N; Brais LK; Welch MW; Zellers CL; Ng K; Chang DT; Miksad RA; Bullock AJ; Tseng JF; Swanson RS; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Hornick JL; Ogino S; Fuchs CS; Hezel AF; Koong AC; Wolpin BM
Br J Cancer; 2017 Dec; 117(12):1874-1882. PubMed ID: 28982112
[TBL] [Abstract][Full Text] [Related]
8. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer.
Mirkin KA; Hollenbeak CS; Wong J
J Surg Res; 2017 Dec; 220():12-24. PubMed ID: 29180173
[TBL] [Abstract][Full Text] [Related]
9. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
Sierzega M; Popiela T; Kulig J; Nowak K
Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
[TBL] [Abstract][Full Text] [Related]
10. Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer.
Eskander MF; de Geus SW; Kasumova GG; Ng SC; Al-Refaie W; Ayata G; Tseng JF
Surgery; 2017 Apr; 161(4):968-976. PubMed ID: 27865602
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
[TBL] [Abstract][Full Text] [Related]
12. The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery.
Philips P; Dunki-Jacobs E; Agle SC; Scoggins C; McMasters KM; Martin RC
HPB (Oxford); 2014 Dec; 16(12):1051-5. PubMed ID: 25123504
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
[TBL] [Abstract][Full Text] [Related]
15. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
[TBL] [Abstract][Full Text] [Related]
16. Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?
Janot MS; Kersting S; Belyaev O; Matuschek A; Chromik AM; Suelberg D; Uhl W; Tannapfel A; Bergmann U
Langenbecks Arch Surg; 2012 Aug; 397(6):917-25. PubMed ID: 22695970
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas.
Pomianowska E; Westgaard A; Mathisen Ø; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Jan; 20(1):233-41. PubMed ID: 22893118
[TBL] [Abstract][Full Text] [Related]
18. Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma.
Malleo G; Maggino L; Ferrone CR; Marchegiani G; Mino-Kenudson M; Capelli P; Rusev B; Lillemoe KD; Bassi C; Fernàndez-Del Castillo C; Salvia R
Ann Surg; 2019 Dec; 270(6):1138-1146. PubMed ID: 29672406
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
You DD; Lee HG; Heo JS; Choi SH; Choi DW
J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]